Mark Cuban’s war on America’s $5 trillion healthcare machine: ‘They can’t react as quickly’

Mark Cuban, the billionaire entrepreneur, has launched a new initiative to tackle the high costs of healthcare in the United States. Cost Plus Drugs, launched in 2022, aims to disrupt the traditional pharmacy industry by providing transparent pricing and reducing drug costs for consumers. Cuban claims that drug prices are deliberately opaque, making it difficult for consumers to understand the true cost of medications. Cost Plus Drugs aims to pull back the curtain on drug pricing and offer drugs at a markup of just 15% over the wholesale cost, significantly undercutting the prices charged by traditional pharmacies. The initiative is seen as a direct challenge to the $5 trillion healthcare industry, which Cuban believes is slow to react to disruptive changes. By offering affordable and transparent pricing, Cost Plus Drugs hopes to shake up the industry and provide consumers with a more accessible and affordable healthcare option.